CoWin registration for immunisation of children aged 15-18 started : Mandaviya

New Delhi : Registration for vaccination of children in the 15-18 age group against COVID-19 starts today on New Year on the CoWIN portalUnion Health Minister Mansukh Mandaviya informed.

Requesting people to register eligible children in their families for this, Mandaviya tweeted, “On the occasion of New Year, registration is being started on CoWIN portal for immunization of children against #COVID19 in the age group of 15 to 18 years from today. I request the family members to register the eligible children for vaccination. #SabkoVaccineMuftVaccine.”

The government has said both walk-in and online registration will be available for vaccination of children ged between 15 to 18, who can start getting doses against COVID-19 on January 3.

While the CoWin registrations will begin from Saturday, the onsite registration will commence from the day of vaccination i.e. January 3 itself.

According to the government’s guidelines, children can book slots on the CoWin app using their ID cards from January 1.

Earlier Dr R S Sharma, Cowin platform chief, confirmed that besides Aadhaar and other national identity cards, children can use their class 10th ID card for registration.

Recently, Union Health Secretary, Rajesh Bhushan chaired a workshop through video conference with all states and union territories (UTs) to review the rollout of vaccination for the age group 15-18 and precautionary third dose for vulnerable categories – healthcare workers (HCW), frontline workers (FLW), and those in the 60 age group who have co-morbidity.

The Centre has also advised states to establish separate dedicated COVID-19 vaccination centers for kids aged 15-18 while a separate vaccination team and separate queues to be maintained at all other CVCs.

On December 25, 2021, Prime Minister Narendra Modi, announced that children aged 15-18 years will begin getting a vaccine against Covid-19 from January 3, 2022, and healthcare and frontline workers will start receiving precautionary doses from January 10.

Bharat Biotech’s Covaxin, which has been granted approval for restricted use in an emergency situation in the age group between 12 and 18 years, is the only vaccine available for children.

  • Related Posts

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Andelyn bio sciences Inc, a leading patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Queen’s University to develop and manufacture AAV9-GM2, a gene therapy…

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    Cellution Biologics Inc, a biologics company focused on developing, manufacturing and commercializing advanced human tissue-based products, announced the completion of its acquisition of the SimpliDerm hydrated human acellular dermal matrix…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

    ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

    US appeals court sides with Sun Pharma in Lipitor antitrust case

    US appeals court sides with Sun Pharma in Lipitor antitrust case

    Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

    Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

    Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad

    Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad